Clinical Trials
Latina immigrants' breast and colon cancer causal attributions: genetics is key
doi: 10.1007/s12687-023-00681-9. Online ahead of print. Affiliations Expand ...
Summit Explores Ways to Improve Care Access, Research for Underserved Communities
A recent associated disease summit brought together the rare disease community to discuss challenges in increasing disease awareness and clinical t...
Structural Racism and Lung Cancer Risk: A Scoping Review
Importance: Structural racism is associated with persistent inequities in health and health outcomes in the US for racial and ethnic...
Sharing and seeking information about skin cancer risk and prevention among Hispanic people from Florida and Puerto Rico
Objective: To explore factors associated with communication and information-seeking after receipt of skin cancer prevention informat...
CMS sees Hispanic and Asian enrollment rise while Black and white numbers drop | WFAE 90.7
Charlotte-Mecklenburg Schools continues its slow shift to a more racially diverse district, with increases in Hispanic and Asian students offsettin...
AI Models in Prostate Cancer Tackle Treatment Disparities Facing African American Men
Rana McKay, MD Medical Oncologist Associate Professor of Medicine University of California San Diego Health San Diego, CA Targeted Oncology: W...

Trending Topics

Features

Download and distribute powerful vaccination QI resources for your community.

Sign up now to support health equity and sustainable health outcomes in your community.

MCED tests use a simple blood draw to screen for many kinds of cancer at once.

FYHN is a bridge connecting health information providers to BIPOC communities in a trusted environment.

Discover an honest look at our Medicare system.

ARC was launched to create a network of community clinicians to diversify and bring clinical trials to communities of color and other communities that have been underrepresented.

The single most important purpose of our healthcare system is to reduce patient risk for an acute event.